Patents by Inventor Maya Nagasawa

Maya Nagasawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENGINEERED HEPATITIS B CORE POLYPEPTIDE
    Publication number: 20220281924
    Abstract: Genetically modified HBc polypeptides are provided.
    Type: Application
    Filed: January 21, 2022
    Publication date: September 8, 2022
    Inventors: James R. Swartz, Rinchu Mathew, Marcus John Rohovie, Maya Nagasawa
  • ENGINEERED CD47 EXTRACELLULAR DOMAIN FOR BIOCONJUGATION
    Publication number: 20220135650
    Abstract: Compositions and methods are provided relating to engineered CD47 extracellular domain (ECD) proteins.
    Type: Application
    Filed: March 2, 2020
    Publication date: May 5, 2022
    Inventors: James R. Swartz, Maya Nagasawa
  • Engineered hepatitis B core polypeptide
    Patent number: 11261216
    Abstract: Genetically modified HBc polypeptides are provided.
    Type: Grant
    Filed: December 23, 2019
    Date of Patent: March 1, 2022
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: James R. Swartz, Rinchu Mathew, Marcus John Rohovie, Maya Nagasawa
  • ENGINEERED HEPATITIS B CORE POLYPEPTIDE
    Publication number: 20200231632
    Abstract: Genetically modified HBc polypeptides are provided.
    Type: Application
    Filed: December 23, 2019
    Publication date: July 23, 2020
    Inventors: James R. Swartz, Rinchu Mathew, Marcus John Rohovie, Maya Nagasawa